Phase 2 Hypogonadism Clinical Trials
10 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–10 of 10 trials
Recruiting
Phase 2
Testosterone Treatment in Men With Chronic Kidney Disease
Hypogonadism, MaleKidney Disease, Chronic
St. Louis University20 enrolled1 locationNCT05249634
Recruiting
Phase 2
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
PainOpioid UseHypogonadism, Male
Brigham and Women's Hospital150 enrolled1 locationNCT04798469
Recruiting
Phase 2
Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
CancerFatigueHypogonadism, Male
Seattle Institute for Biomedical and Clinical Research230 enrolled3 locationsNCT04301765
Recruiting
Phase 2
Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea
Hypogonadotropic HypogonadismHypothalamic Amenorrhea
Stephanie B. Seminara, MD20 enrolled1 locationNCT07224438
Recruiting
Phase 2
Kisspeptin Administration Subcutaneously to Patients With IHH
Hypogonadotropic Hypogonadism
Stephanie B. Seminara, MD36 enrolled1 locationNCT05896293
Recruiting
Phase 2
Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
Central Nervous System DiseasesGenital Diseases, MaleHypogonadism+17 more
North Florida Foundation for Research and Education21 enrolled2 locationsNCT04460872
Recruiting
Phase 2
Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
Hypogonadism, MaleFatigue Syndrome, Chronic
Seattle Institute for Biomedical and Clinical Research240 enrolled2 locationsNCT04049331
Terminated
Phase 2Phase 3
Biological actions of estradiol in men trial
Prostate CancerHypogonadism
University of Melbourne130 enrolled1 locationACTRN12614000689673
Completed
Phase 2
The safety and effectiveness of testosterone pellet implantation in hypogonadal males
Hypogonadism
Auxilium Pharmaceuticals, Inc.24 enrolled1 locationACTRN12614000604606
Completed
Phase 2
Bioequivalence study comparing AndroForte 5 (Registered Trademark (R)) and Testogel (R) 1%
Testosterone replacement therapyHypogonadism
Lawley Pharmaceuticals16 enrolled1 locationACTRN12610000834055